Silexion Therapeutics Corp
SLXNW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002022416
No open-market purchases or sales by Silexion Therapeutics Corp insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $70.3K in total; no superinvestor holds it.
Other share classesSLXN
Holders of 5% or more of SLXNW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Silexion Therapeutics Corp, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Silexion Therapeutics Corp on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Silexion Therapeutics Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 202610:21 AM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 0.00%0 shares | –Below 5% | Jun 30, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Silexion Therapeutics Corp shares.
No Form 144 notices for Silexion Therapeutics Corp are on file.